Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose, Vitamin D, and Calcium for bone mass in postmenopausal women
NCT00160264Phase 4Completed
- Sponsor
- Solvay
- Start
- Jan 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lactulose in osteopenia (2 arms), sponsored by Solvay. Primary endpoint: Bone mass preservation by bone densitometry values at 1 year. Started Jan 2003; status: completed.
02
Drugs
lactulose
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00160264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160264.